Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Hypertension Awareness Remains Low with Consumers, According to Recently Released Data from Kantar Health

Published: Thursday, April 04, 2013
Last Updated: Thursday, April 04, 2013
Bookmark and Share
New data from the National Health and Wellness Survey shows diagnosis rates vary widely by country.

Despite the rising prevalence of hypertension worldwide, the number of patients diagnosed with the disease remains low when compared with estimated prevalence, according to new findings from Kantar Health’s National Health and Wellness Survey (NHWS). The NHWS finds that diagnosis rates vary significantly from country to country and currently range from 74 percent of the estimated hypertensive population in the United States to 25 percent in China. The World Health Organization estimates that one in three people have hypertension worldwide, but because it is asymptomatic many patients are not aware of their condition and are not receiving a diagnosis.

The NHWS finds that less than one-third of patients in Asia and less than one-half of patients in the 5EU (France, Germany, Italy, Spain and the United Kingdom) who are estimated to have hypertension have been diagnosed. Diagnosis is highest in the United States at 74 percent. Once patients are diagnosed treatment rates are high, ranging from 72 percent of diagnosed patients in Brazil to 86 percent in Japan.

“Hypertension is often called ‘the silent killer’ because it is largely asymptomatic,” said Gina Isherwood, Ph.D., regional brand director at Kantar Health. “High blood pressure increases the risk of heart attacks, stroke, kidney failure and blindness, and it is both preventable and treatable. But many people with high blood pressure are not aware of their condition, do not see a physician, and therefore are not being treated, even though many low-cost treatments are available.”

Many people who do not currently have hypertension have a family history (e.g., hypertension, cardiovascular disease and diabetes) that increases their risk of developing this condition. Despite this risk many engage in unhealthy behaviors such as alcohol consumption, tobacco use and sedentary lifestyles.

“The risk of developing high blood pressure can be mitigated by making lifestyle changes such as eating a balanced diet, exercising regularly and not using tobacco products,” Dr. Isherwood said. “The fact that many of these high-risk patients are not making lifestyle changes that could lower their risk highlights that a gap remains in communicating the dangers of hypertension to patients.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Key Piece of MRSA Vaccine Puzzle
New research funded by the Health Research Board and the Wellcome Trust has pinpointed immune cells that could be targeted by an MRSA vaccine.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos